LB Pharmaceuticals, Inc. (LBRX)
39.42
+0.19
(+0.48%)
USD |
NASDAQ |
Oct 22, 16:00
39.77
+0.35
(+0.89%)
After-Hours: 20:00
LB Pharmaceuticals Market Cap : 1.131B for Oct. 22, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 22, 2026 | 1.131B |
| October 21, 2026 | 1.125B |
| October 20, 2026 | 1.176B |
| October 19, 2026 | 1.113B |
| October 16, 2026 | 1.054B |
| October 15, 2026 | 1.052B |
| October 14, 2026 | 975.16M |
| October 13, 2026 | 997.82M |
| October 12, 2026 | 1.031B |
| October 09, 2026 | 1.068B |
| October 08, 2026 | 992.65M |
| October 07, 2026 | 979.75M |
| October 06, 2026 | 982.61M |
| October 05, 2026 | 992.94M |
| October 02, 2026 | 1.061B |
| October 01, 2026 | 1.069B |
| September 30, 2026 | 1.101B |
| September 29, 2026 | 1.069B |
| September 28, 2026 | 1.087B |
| September 25, 2026 | 1.071B |
| September 24, 2026 | 1.084B |
| September 23, 2026 | 1.124B |
| September 22, 2026 | 1.224B |
| September 21, 2026 | 1.233B |
| September 18, 2026 | 1.218B |
| Date | Value |
|---|---|
| September 17, 2026 | 1.209B |
| September 16, 2026 | 1.221B |
| September 15, 2026 | 1.234B |
| September 14, 2026 | 1.286B |
| September 11, 2026 | 1.280B |
| September 10, 2026 | 1.327B |
| September 09, 2026 | 1.367B |
| September 08, 2026 | 1.417B |
| September 04, 2026 | 1.415B |
| September 03, 2026 | 1.363B |
| September 02, 2026 | 1.419B |
| September 01, 2026 | 1.351B |
| August 31, 2026 | 1.355B |
| August 28, 2026 | 1.369B |
| August 27, 2026 | 1.374B |
| August 26, 2026 | 1.381B |
| August 25, 2026 | 1.400B |
| August 24, 2026 | 1.383B |
| August 21, 2026 | 1.366B |
| August 20, 2026 | 1.355B |
| August 19, 2026 | 1.404B |
| August 18, 2026 | 1.399B |
| August 17, 2026 | 1.326B |
| August 14, 2026 | 1.370B |
| August 13, 2026 | 1.270B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ligand Pharmaceuticals, Inc. | 6.132B |
| ANI Pharmaceuticals, Inc. | 1.694B |
| Corcept Therapeutics, Inc. | 11.60B |
| Veru, Inc. | 39.05M |
| Johnson & Johnson | 644.17B |
Market Cap Related Metrics
| PEG Ratio | -0.1001 |
| Price to Book Value | 3.402 |
| Price | 39.42 |
| Earnings Yield | -7.56% |
| PEGY Ratio | -0.1001 |